Glibenfage, 5 mg+500 mg 30 pcs

Type 2 diabetes mellitus in adults:

• when diet therapy, exercise, and prior monotherapy with metformin or sulfonylurea derivatives are ineffective;
• to replace prior therapy with two drugs (metformin and sulfonylurea derivative) in patients with stable and adequate glycemic control.

.

Active ingredient

Composition

Active ingredients:

Glibenclamide 5 mg + metformin hydrochloride 500 mg;

Auxiliary substances:

Core:

Hypromellose – 16.0 mg,

croscarmellose sodium – 18.0 mg,

Sodium stearyl fumarate – 7.0,

povidone K30 – 15.0 mg,

povidone (collidone F90) – 19.0 mg;

Composition of the film coating:

Hypromellose E15 – 7.0 mg, macrogol 6000 (polyethylene glycol 6000) – 0.9 mg, titanium dioxide – 2.0 mg, polysorbate 80 (Tween 80) – 0.1 mg.

How to take, the dosage

Special Instructions

Contraindications

Side effects

Overdose

Pregnancy use

The use of the combination of glibenclamide and metformin is contraindicated during pregnancy. The patient should be warned that during treatment with the drug Glibenfazh it is necessary to inform the doctor about the planned pregnancy and the onset of pregnancy. If pregnancy is planned, as well as if pregnancy occurs during the period of taking the drug, it should be cancelled and insulin therapy should be prescribed.

The combination of glibenclamide and metformin is contraindicated in breastfeeding because there are no data on its ability to penetrate into breast milk. If it is necessary to use the drug during breastfeeding, switch to insulin therapy or stop breastfeeding.

Similarities